Hans-Peter Kiem
Hans-Peter Kiem is a gene and cell therapy researcher working on editing blood stem cells inside the body.
Physician-scientist leading hematopoietic stem cell gene therapy and in vivo gene delivery research, including glioblastoma chemoprotection strategies and in vivo HSC editing.
| Title | Journal | Year |
|---|---|---|
| Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients | Journal of Clinical Investigation | 2014 |
| Large animal models of hematopoietic stem cell gene therapy | Gene Therapy | 2010 |
Pages like this
not linked directly; found by shared links- InstitutionChildren's Cancer Hospital Egypt 57357
Shares Allogeneic (off-the-shelf) cell therapy, Glioma & glioblastoma, Acute myeloid leukaemia.
- TargetCD70
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia.
- InstitutionGreat Ormond Street Hospital for Children
Shares Allogeneic (off-the-shelf) cell therapy, Glioma & glioblastoma, Acute myeloid leukaemia.
- PersonPhilip D. Greenberg
Shares Fred Hutchinson Cancer Center, Acute myeloid leukaemia.
- PersonStephen J. Forman
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia.
- TargetCD7
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia.
- InstitutionHamad Medical Corporation / National Center for Cancer Care and Research
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia.
- InstitutionRamathibodi Hospital, Mahidol University
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia.